BioCentury
ARTICLE | Clinical News

Vestar Inc. regulatory update

September 26, 1994 7:00 AM UTC

Vestar Inc. (VSTR) The San Dimas, Calif., company's AmBisome was approved for sale in Sweden to treat visceral leishmaniasis, a parasitic disorder that causes fever, swelling of the liver and spleen ...